Endava PLC (ADR) (DAVA) PT Raised to $180 at Cowen

Cowen analyst Bryan Bergin raised the price target on Endava PLC (ADR) (NYSE: DAVA) to $180.00 (from $170.00) while maintaining an Outperform rating.

The analyst commented, "Strong 1Q and DAVA conveyed incremental bullishness on its view for med-term organic growth of low-to mid-20% driven by broad-based demand tailwinds & pricing power. Global workforce investments continue as DAVA builds nearshore capabilities to sustain trajectory & drive diversification. Despite cost pressure, margin stands above pre-COVID levels (and peers) which is a welcome surprise. PT $180."

You May Also Be Interested In

• CIENA (CIEN) PT Lowered to $375 at Evercore ISI
• JPMorgan Upgrades Cosmo Energy Holdings (5021:JP) to Overweight
• CLSA Upgrades Taiyo Yuden Co Ltd (6976:JP) (TYOYY) to High-Conviction Outperform (1)